Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Gazanfar Rahmathulla, Elizabeth J Hovey, Neda Hashemi-Sadraei & Manmeet S Ahluwalia. (2013) Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challenges. OncoTargets and Therapy 6, pages 371-389.
Read now
Read now
Sajeel Chowdhary & Marc Chamberlain. (2013) Bevacizumab for the treatment of glioblastoma. Expert Review of Neurotherapeutics 13:8, pages 937-949.
Read now
Read now
Göksemin Acar, Gamze Tanrıöver & Ramazan Demir. (2012) Angiogenesis in neurological disorders: a review. Neurological Research 34:7, pages 627-635.
Read now
Read now
Jasmin Jo, David Schiff & Benjamin Purow. (2012) Angiogenic inhibition in high-grade gliomas: past, present and future. Expert Review of Neurotherapeutics 12:6, pages 733-747.
Read now
Read now
Marc Chamberlain. (2011) Evolving strategies: future treatment of glioblastoma. Expert Review of Neurotherapeutics 11:4, pages 519-532.
Read now
Read now
Michael S Gordon. (2011) Antiangiogenic therapies: is VEGF-A inhibition alone enough?. Expert Review of Anticancer Therapy 11:3, pages 485-496.
Read now
Read now
Darren Hargrave. (2009) Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy. British Journal of Neurosurgery 23:4, pages 351-363.
Read now
Read now
Articles from other publishers (60)
Lu Sun, Yuelin Jiang, Hong Tan & Ruichao Liang. (2024) Collagen and derivatives-based materials as substrates for the establishment of glioblastoma organoids. International Journal of Biological Macromolecules 254, pages 128018.
Crossref
Crossref
Heena Sareen, Yafeng Ma, Therese M. Becker, Tara L. Roberts, Paul de Souza & Branka Powter. (2022) Molecular Biomarkers in Glioblastoma: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 23:16, pages 8835.
Crossref
Crossref
Ruslan A. Zukov, Denis V. Chernyaev & Alexandra R. Zulkaidarova. (2022) Combination therapy regimens in the treatment of metastatic renal cell carcinoma: A review. Journal of Modern Oncology 24:2, pages 191-198.
Crossref
Crossref
T. A. Khalimov. (2021) Features of angiogenesis in eye diseases. RUDN Journal of Medicine 25:2, pages 106-113.
Crossref
Crossref
Fan Wang, CaiYan Li, Fei Han, LvAn Chen & Ling Zhu. (2021) BMAL1 may be involved in angiogenesis and peritumoral cerebral edema of human glioma by regulating VEGF and ANG2. Aging 13:22, pages 24675-24685.
Crossref
Crossref
Eliane Klein, Ann-Christin Hau, Anaïs Oudin, Anna Golebiewska & Simone P. Niclou. (2020) Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy. Frontiers in Oncology 10.
Crossref
Crossref
Muhammad Farooq, Fahad A. Nasr, Nawaf D. Almoutiri, Nouf Al-yahya, Mohammad Ahmed Wadaan & Nael Abutaha. (2020) The phytochemical screening and antiangiogenic activity of audthan al himar (Moricandia sinaica Boiss.) extracts in zebrafish embryos and human umbilical vein endothelial cells. Journal of King Saud University - Science 32:4, pages 2370-2376.
Crossref
Crossref
Qing Hu, Feng Liu, Tengfeng Yan, Miaojing Wu, Minhua Ye, Guangyao Shi, Shigang Lv & Xingen Zhu. (2019) MicroRNA‑576‑3p inhibits the migration and proangiogenic abilities of hypoxia‑treated glioma cells through hypoxia‑inducible factor‑1α. International Journal of Molecular Medicine.
Crossref
Crossref
Wen-Yu Cheng, Chiung-Chyi Shen, Ming-Tsang Chiao, Yea-Jiuan Liang, Tsuo-Fei Mao, Bai-Shuan Liu & Jun-Peng Chen. (2018) High expression of a novel splicing variant of VEGF, L-VEGF144 in glioblastoma multiforme is associated with a poorer prognosis in bevacizumab treatment. Journal of Neuro-Oncology 140:1, pages 37-47.
Crossref
Crossref
Eskil Eskilsson, Gro V Røsland, Gergely Solecki, Qianghu Wang, Patrick N Harter, Grazia Graziani, Roel G W Verhaak, Frank Winkler, Rolf Bjerkvig & Hrvoje Miletic. (2018) EGFR heterogeneity and implications for therapeutic intervention in glioblastoma. Neuro-Oncology 20:6, pages 743-752.
Crossref
Crossref
Xin Cui, Renee-Tyler Tan Morales, Weiyi Qian, Haoyu Wang, Jean-Pierre Gagner, Igor Dolgalev, Dimitris Placantonakis, David Zagzag, Luisa Cimmino, Matija Snuderl, Raymond H.W. Lam & Weiqiang Chen. (2018) Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis. Biomaterials 161, pages 164-178.
Crossref
Crossref
Maria Grazia Atzori, Lucio Tentori, Federica Ruffini, Claudia Ceci, Lucia Lisi, Elena Bonanno, Manuel Scimeca, Eskil Eskilsson, Thomas Daubon, Hrvoje Miletic, Lucia Ricci Vitiani, Roberto Pallini, Pierluigi Navarra, Rolf Bjerkvig, Stefania D’Atri, Pedro Miguel Lacal & Grazia Graziani. (2017) The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells. Journal of Experimental & Clinical Cancer Research 36:1.
Crossref
Crossref
Peng Zhao, Anjing Chen, Qichao Qi, Wenjing Zhou, Zichao Feng, Jiwei Wang, Ning Yang, Xingang Li, Jian Wang, Qibing Huang & Bin Huang. (2017)
Impact of
VEGFA
polymorphisms on glioma risk in Chinese
. Oncotarget 8:48, pages 83712-83722.
Crossref
Crossref
Shivanjali Saxena & Sushmita Jha. (2017) Role of NOD- like Receptors in Glioma Angiogenesis: Insights into future therapeutic interventions. Cytokine & Growth Factor Reviews 34, pages 15-26.
Crossref
Crossref
Aurélien Corroyer-Dulmont, Elodie A. Pérès, Aurélie N. Gérault, Ariel Savina, Fanny Bouquet, Didier Divoux, Jérôme Toutain, Méziane Ibazizène, Eric T. MacKenzie, Louisa Barré, Myriam Bernaudin, Edwige Petit & Samuel Valable. (2015) Multimodal imaging based on MRI and PET reveals [18F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma. European Journal of Nuclear Medicine and Molecular Imaging 43:4, pages 682-694.
Crossref
Crossref
ZHIYUN YU, GANG ZHAO, ZHONGHUA ZHANG, YUNQIAN LI, YONG CHEN, NAN WANG, ZHONGYING ZHAO & GUIFANG XIE. (2016) Efficacy and safety of bevacizumab for the treatment of glioblastoma. Experimental and Therapeutic Medicine 11:2, pages 371-380.
Crossref
Crossref
. 2016. Imaging in Neurology. Imaging in Neurology
131
.
. 2016. Diagnostic Imaging: Brain. Diagnostic Imaging: Brain
442
445
.
John Kealy & Matthew Campbell. 2016. Resistance to Targeted Therapies Against Adult Brain Cancers. Resistance to Targeted Therapies Against Adult Brain Cancers
69
87
.
Annelise Letourneur, Simon Roussel, Myriam Bernaudin, Fabien Fillesoye, Jérôme Toutain, Eric T MacKenzie, Edwige Petit, Omar Touzani & Samuel Valable. (2015) Chronic arterial hypertension impedes glioma growth: a multiparametric MRI study in the rat. Hypertension Research 38:11, pages 723-732.
Crossref
Crossref
Huan-Huan Wu, Shuai Zhang, Huan Bian, Xiao-Xu Li, Lin Wang, Yin-Fei Pu, Yi-Xiang Wang & Chuan-Bin Guo. (2015) Bevacizumab Regulates Cancer Cell Migration by Activation of STAT3. Asian Pacific Journal of Cancer Prevention 16:15, pages 6501-6506.
Crossref
Crossref
Christopher Bell, Nicholas Dowson, Simon Puttick, Yaniv Gal, Paul Thomas, Mike Fay, Jye Smith & Stephen Rose. (2015) Increasing feasibility and utility of 18 F-FDOPA PET for the management of glioma. Nuclear Medicine and Biology 42:10, pages 788-795.
Crossref
Crossref
Christopher Bell, Nicholas Dowson, Mike Fay, Paul Thomas, Simon Puttick, Yaniv Gal & Stephen Rose. (2015) Hypoxia Imaging in Gliomas With 18F-Fluoromisonidazole PET: Toward Clinical Translation. Seminars in Nuclear Medicine 45:2, pages 136-150.
Crossref
Crossref
Bin Hu, Luni Emdad, Manny D. Bacolod, Timothy P. Kegelman, Xue-Ning Shen, Mohammad A. Alzubi, Swadesh K. Das, Devanand Sarkar & Paul B. Fisher. (2014) Astrocyte Elevated Gene-1 Interacts with Akt Isoform 2 to Control Glioma Growth, Survival, and Pathogenesis. Cancer Research 74:24, pages 7321-7332.
Crossref
Crossref
Ann Junghans, Mary Jo Waltman, Hillary L. Smith, Luka Pocivavsek, Noureddine Zebda, Konstantin Birukov, Mariano Viapiano & Jaroslaw Majewski. (2014) Understanding dynamic changes in live cell adhesion with neutron reflectometry. Modern Physics Letters B 28:30, pages 1430015.
Crossref
Crossref
Thomas Simon, Bérénice Coquerel, Alexandre Petit, Yusra Kassim, Elise Demange, Didier Le Cerf, Valérie Perrot & Jean-Pierre Vannier. (2014) Direct Effect of Bevacizumab on Glioblastoma Cell Lines In Vitro. NeuroMolecular Medicine 16:4, pages 752-771.
Crossref
Crossref
Onat Kadioglu, Ean Jeong Seo & Thomas Efferth. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
823
850
.
Paladd Asavarut, Kevin O'Neill, Nelofer Syed & Amin Hajitou. (2014) Chimeric adeno-associated virus and bacteriophage: a potential targeted gene therapy vector for malignant glioma. Therapeutic Delivery 5:9, pages 975-990.
Crossref
Crossref
Xing-Yu Hong, Jing Wang & Zhe Li. (2013) AGR2 Expression is Regulated by HIF-1 and Contributes to Growth and Angiogenesis of Glioblastoma. Cell Biochemistry and Biophysics 67:3, pages 1487-1495.
Crossref
Crossref
Benjamin Goeppert, Christopher R. Schmidt, Lea Geiselhart, Céline Dutruel, David Capper, Marcus Renner, Monika Nadja Vogel, Cornelia Zachskorn, Jenny Zinke, Benito Campos, Peter Schmezer, Odilia Popanda, Wolfgang Wick, Michael Weller, Richard Meyermann, Jens Schittenhelm, Patrick Nikolaus Harter, Perikles Simon, Wilko Weichert, Peter Schirmacher, Christoph Plass & Michel Mittelbronn. (2013) Differential Expression of the Tumor Suppressor A-Kinase Anchor Protein 12 in Human Diffuse and Pilocytic Astrocytomas Is Regulated by Promoter Methylation. Journal of Neuropathology & Experimental Neurology 72:10, pages 933-941.
Crossref
Crossref
Thomas Viel, Philipp Boehm-Sturm, Sara Rapic, Parisa Monfared, Bernd Neumaier, Mathias Hoehn & Andreas H. Jacobs. (2013) Non-invasive imaging of glioma vessel size and densities in correlation with tumour cell proliferation by small animal PET and MRI. European Journal of Nuclear Medicine and Molecular Imaging 40:10, pages 1595-1606.
Crossref
Crossref
Joachim Høg Mortensen, Maria Jeppesen, Linda Pilgaard, Ralf Agger, Meg Duroux, Vladimir Zachar & Torben Moos. (2013)
Targeted Antiepidermal Growth Factor Receptor (Cetuximab) Immunoliposomes Enhance Cellular Uptake
In Vitro
and Exhibit Increased Accumulation in an Intracranial Model of Glioblastoma Multiforme
. Journal of Drug Delivery 2013, pages 1-13.
Crossref
Crossref
Nicolas Goffart, Jérôme Kroonen & Bernard Rogister. (2013) Glioblastoma-Initiating Cells: Relationship with Neural Stem Cells and the Micro-Environment. Cancers 5:4, pages 1049-1071.
Crossref
Crossref
Shixian Huang, Kun Shao, Yang Liu, Yuyang Kuang, Jianfeng Li, Sai An, Yubo Guo, Haojun Ma & Chen Jiang. (2013) Tumor-Targeting and Microenvironment-Responsive Smart Nanoparticles for Combination Therapy of Antiangiogenesis and Apoptosis. ACS Nano 7:3, pages 2860-2871.
Crossref
Crossref
Thaís Heinke, Kleber Simões do Espiríto Santo, Adhemar Longatto Filho & João Norberto Stavale. (2013) Vascular endothelial growth factor and KIT expression in relation with microvascular density and tumor grade in supratentorial astrocytic tumors. Acta Cirurgica Brasileira 28:1, pages 48-54.
Crossref
Crossref
Aurélien Corroyer-Dulmont, Elodie A. Pérès, Edwige Petit, Jean-Sébastien Guillamo, Nathalie Varoqueaux, Simon Roussel, Jérôme Toutain, Didier Divoux, Eric T. MacKenzie, Jérôme Delamare, Méziane Ibazizène, Myriam Lecocq, Andréas H. Jacobs, Louisa Barré, Myriam Bernaudin & Samuel Valable. (2013) Detection of glioblastoma response to temozolomide combined with bevacizumab based on µMRI and µPET imaging reveals [18F]-fluoro-l-thymidine as an early and robust predictive marker for treatment efficacy. Neuro-Oncology 15:1, pages 41-56.
Crossref
Crossref
ZHIQIANG GAO, PENG CHENG, YIXUE XUE & YUNHUI LIU. (2012) Vascular endothelial growth factor participates in modulating the C6 glioma-induced migration of rat bone marrow-derived mesenchymal stem cells and upregulates their vascular cell adhesion molecule-1 expression. Experimental and Therapeutic Medicine 4:6, pages 993-998.
Crossref
Crossref
Flavia R.S. Lima, Suzana Assad Kahn, Rossana C. Soletti, Deborah Biasoli, Tercia Alves, Anna Carolina C. da Fonseca, Celina Garcia, Luciana Romão, José Brito, Rosenilde Holanda-Afonso, Jane Faria, Helena Borges & Vivaldo Moura-Neto. (2012) Glioblastoma: Therapeutic challenges, what lies ahead. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1826:2, pages 338-349.
Crossref
Crossref
Lothar C Dieterich, Sofie Mellberg, Elise Langenkamp, Lei Zhang, Agata Zieba, Henriikka Salomäki, Martin Teichert, Hua Huang, Per-Henrik Edqvist, Theo Kraus, Hellmut G Augustin, Tommie Olofsson, Erik Larsson, Ola Söderberg, Grietje Molema, Fredrik Pontén, Patrik Georgii-Hemming, Irina Alafuzoff & Anna Dimberg. (2012) Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization. The Journal of Pathology 228:3, pages 378-390.
Crossref
Crossref
Emily S Day, Linna Zhang, Patrick A Thompson, Janice A Zawaski, Caterina C Kaffes, M Waleed Gaber, Susan M Blaney & Jennifer L West. (2012) Vascular-targeted photothermal therapy of an orthotopic murine glioma model. Nanomedicine 7:8, pages 1133-1148.
Crossref
Crossref
Bin Hu, Mohan S. Nandhu, Hosung Sim, Paula A. Agudelo-Garcia, Joshua C. Saldivar, Claire E. Dolan, Maria E. Mora, Gerard J. Nuovo, Susan E. Cole & Mariano S. Viapiano. (2012) Fibulin-3 Promotes Glioma Growth and Resistance through a Novel Paracrine Regulation of Notch Signaling. Cancer Research 72:15, pages 3873-3885.
Crossref
Crossref
Lingchao Chen, Lei Han, Kailiang Zhang, Zhendong Shi, Junxia Zhang, Anling Zhang, Yongzhi Wang, Yijun Song, Yongli Li, Tao Jiang, Peiyu Pu, Chuanlu Jiang & Chunsheng Kang. (2012) VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling. Neuro-Oncology 14:8, pages 1026-1036.
Crossref
Crossref
M. Crocker, S. Saadoun, A. Jury, C. Jones, S. Zacharoulis, S. Thomas, R. Zwiggelaar, L. R. Bridges, B. A. Bell & M. C. Papadopoulos. (2012) Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion. Neuro-Oncology 14:5, pages 641-648.
Crossref
Crossref
S. A. Shein, O. I. Gurina, A. V. Leopol’d, V. P. Baklaushev, A. A. Korchagina, N. F. Grinenko, N. V. Ivanova, N. E. Volgina, I. A. Ryabukhin & V. P. Chekhonin. (2012) Generation of Monoclonal Antibodies to Recombinant Vascular Endothelial Growth Factor. Bulletin of Experimental Biology and Medicine 153:1, pages 139-142.
Crossref
Crossref
E. Bourseau-Guilmain, J. Béjaud, A. Griveau, N. Lautram, F. Hindré, M. Weyland, J.P. Benoit & E. Garcion. (2012) Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133. International Journal of Pharmaceutics 423:1, pages 93-101.
Crossref
Crossref
S. Grau, J. Thorsteinsdottir, L. von Baumgarten, F. Winkler, J.-C. Tonn & C. Schichor. (2011) Bevacizumab can induce reactivity to VEGF-C and -D in human brain and tumour derived endothelial cells. Journal of Neuro-Oncology 104:1, pages 103-112.
Crossref
Crossref
Bryan Simard, Ali Bouamrani, Peggy Jourdes, Gilles Pernod, Violetta Dimitriadou & François Berger. (2011) Induction of the fibrinolytic system by cartilage extract mediates its antiangiogenic effect in mouse glioma. Microvascular Research 82:1, pages 6-17.
Crossref
Crossref
Ren-Yuan Bai, Verena Staedtke & Gregory J. Riggins. (2011) Molecular targeting of glioblastoma: Drug discovery and therapies. Trends in Molecular Medicine 17:6, pages 301-312.
Crossref
Crossref
Mark L. Bernstein. (2011) Targeted therapy in pediatric and adolescent oncology. Cancer 117:S10, pages 2268-2274.
Crossref
Crossref
Nicholas Butowski. (2011) Anti-angiogenic therapy in glioma. Clinical and Translational Oncology 13:5, pages 294-300.
Crossref
Crossref
Samuel Valable, Edwige Petit, Simon Roussel, Léna Marteau, Jérôme Toutain, Didier Divoux, Franck Sobrio, Jérôme Delamare, Louisa Barré & Myriam Bernaudin. (2011) Complementary information from magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model. Nuclear Medicine and Biology.
Crossref
Crossref
Sabrina Facchino, Mohamed Abdouh & Gilbert Bernier. (2011) Brain Cancer Stem Cells: Current Status on Glioblastoma Multiforme. Cancers 3:2, pages 1777-1797.
Crossref
Crossref
Olivier KeunenMikael JohanssonAnaïs OudinMorgane SanzeySiti A. Abdul RahimFred FackFrits ThorsenTorfinn TaxtMichal BartosRadovan Jirik, Hrvoje Miletic, Jian WangDaniel StieberLinda StuhrIngrid MoenCecilie Brekke RyghRolf BjerkvigSimone P. Niclou. (2011) Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proceedings of the National Academy of Sciences 108:9, pages 3749-3754.
Crossref
Crossref
Beatriz Valle-Argos, Diego Gómez-Nicola & Manuel Nieto-Sampedro. (2011) Neurostatin blocks glioma cell cycle progression by inhibiting EGFR activation. Molecular and Cellular Neuroscience 46:1, pages 89-100.
Crossref
Crossref
Donald J. AbrahamRobertson Graeme. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
223
294
.
Lin Cheng, Shideng Bao & Jeremy N. Rich. (2010) Potential therapeutic implications of cancer stem cells in glioblastoma. Biochemical Pharmacology 80:5, pages 654-665.
Crossref
Crossref
Xiangdong Liu, Robert C. Newton & Peggy A. Scherle. (2010) Developing c-MET pathway inhibitors for cancer therapy: progress and challenges. Trends in Molecular Medicine 16:1, pages 37-45.
Crossref
Crossref
Nienke A. de Vries, Jos H. Beijnen & Olaf van Tellingen. (2009) High-grade glioma mouse models and their applicability for preclinical testing. Cancer Treatment Reviews 35:8, pages 714-723.
Crossref
Crossref
Inmaculada Segura, Frederik De Smet, Philipp J. Hohensinner, Carmen Ruiz de Almodovar & Peter Carmeliet. (2009) The neurovascular link in health and disease: an update. Trends in Molecular Medicine 15:10, pages 439-451.
Crossref
Crossref
Joachim Silber, C. David James & J. Graeme Hodgson. (2009) microRNAs in Gliomas: Small Regulators of a Big Problem. NeuroMolecular Medicine 11:3, pages 208-222.
Crossref
Crossref